)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
Neumora Therapeutics
Neumora Therapeutics (NMRA) investor relations material
Neumora Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary17 Apr, 2026
Executive summary
Annual meeting scheduled for May 27, 2026, with voting open until May 26, 2026, at 11:59 PM ET.
Shareholders can access proxy materials online or request paper/email copies by May 13, 2026.
Meeting will be held virtually, allowing remote participation and voting.
Voting matters and shareholder proposals
Election of three Class III directors to serve until the 2029 annual meeting or until successors are elected.
Ratification of Ernst & Young LLP as independent auditor for the year ending December 31, 2026.
Advisory vote on executive compensation (say-on-pay).
Advisory vote on the frequency of future say-on-pay votes, with the board recommending an annual vote.
Board of directors and corporate governance
Nominees for Class III director positions are Paul Berns, Matthew Fust, and David Piacquad.
Board recommends voting in favor of all director nominees.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Neumora Therapeutics
- Annual meeting to vote on directors, auditor, executive pay, and key governance matters.NMRA
Proxy filing17 Apr 2026 - Major data for MDD and Alzheimer's agitation expected, with strong financial runway and pipeline progress.NMRA25th Annual Needham Virtual Healthcare Conference13 Apr 2026
- Pipeline advanced with strong cash position and key 2026 clinical milestones ahead.NMRAQ4 202530 Mar 2026
- Advancing novel therapies for brain and metabolic disorders with key milestones expected by 2027.NMRACorporate presentation30 Mar 2026
- NMRA-511 shows strong efficacy in Alzheimer's agitation; pipeline and funding support robust growth.NMRAGuggenheim Securities Emerging Outlook: Biotech Summit 202612 Feb 2026
- Advancing brain-penetrant therapies for obesity, Alzheimer's agitation, and psychiatric disorders.NMRACorporate presentation11 Feb 2026
- Navacaprant’s phase III COASTAL studies for MDD are on track, targeting robust efficacy and safety.NMRAStatus Update20 Jan 2026
- Pivotal Phase 3 data for navacaprant in MDD expected by year-end, with strong cash runway.NMRAQ3 202414 Jan 2026
- Navacaprant's phase 3 trials for MDD target key endpoints, with pivotal data due by 2025.NMRAGuggenheim Securities Inaugural Healthcare Innovation Conference14 Jan 2026
Next Neumora Therapeutics earnings date
Q1 202611 May, 2026
Neumora Therapeutics
Next Neumora Therapeutics earnings date
Q1 202611 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Business philosophy22 Apr 2026
Benedetto Vigna: The CEO of Ferrari
An unexpected leader for Ferrari: how semiconductor expert Benedetto Vigna became CEO and why his background fits the industry's shift.
)
Edge17 Apr 2026
The New York Times Company: Adapting to the Times
How The New York Times Company built on a century-long legacy of trusted journalism to navigate disruption and reshape its business model.
Frequently asked questions
Explore our global coverage